Immusoft Corp:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Immusoft Corp - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10947
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Immusoft Corp (Immusoft) is a biotechnology start-up company that focuses on the development of autologous cell therapy platform for the treatment of genetic diseases. The company’s technology includes immune system programming (ISP) technology, gene delivery technology and lymphopoiesis culture system. It utilizes immune system programming (ISP) technology for the production of long-lived plasma cells from a patient’s B cells that replace defective enzymes or proteins to cure serious disease. Immusoft’s ISP technology finds application in various therapeutic areas including infectious disease, enzyme or protein replacement, regenerative medicine, and cardiovascular disease. The company works in partnerships to develop treatment for atherosclerosis, sarcopenia (muscle loss), and hemophilia. Immusoft is headquartered in Seattle, Washington, the US.

Immusoft Corp – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Immusoft Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Immusoft Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Immusoft Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Immusoft Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Immusoft Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Immusoft Corp, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Immusoft Raises USD3 Million in First Tranche of Series B Financing 10
Immusoft Raises USD2.7 Million in Series A3 Financing 11
Immusoft Raises USD0.4 Million in Venture Financing 12
Immusoft Raises USD2.4 Million in Venture Financing 13
Acquisition 14
Immusoft Acquires Discovery Genomics 14
Immusoft Corp – Key Competitors 15
Immusoft Corp – Key Employees 16
Immusoft Corp – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Recent Developments 18
Corporate Communications 18
Jul 10, 2018: Immusoft Appoints Jason Fontenot As Chief Scientific Officer 18
Jan 05, 2018: Immusoft appoints new CEO to lead gene therapy company 19
Product Approvals 20
May 02, 2018: Immusoft Granted Orphan Drug Designation for Treatment of Rare Childhood Disease 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
Immusoft Corp, Pharmaceuticals & Healthcare, Key Facts 2
Immusoft Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Immusoft Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Immusoft Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Immusoft Corp, Deals By Therapy Area, 2012 to YTD 2018 8
Immusoft Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Immusoft Raises USD3 Million in First Tranche of Series B Financing 10
Immusoft Raises USD2.7 Million in Series A3 Financing 11
Immusoft Raises USD0.4 Million in Venture Financing 12
Immusoft Raises USD2.4 Million in Venture Financing 13
Immusoft Acquires Discovery Genomics 14
Immusoft Corp, Key Competitors 15
Immusoft Corp, Key Employees 16
Immusoft Corp, Subsidiaries 17

List of Figures
Immusoft Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Immusoft Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Immusoft Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Immusoft Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Immusoft Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Immusoft Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Immusoft Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Immusoft Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Immusoft Corp:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • EFU Life Assurance Ltd.:企業の戦略・SWOT・財務情報
    EFU Life Assurance Ltd. - Strategy, SWOT and Corporate Finance Report Summary EFU Life Assurance Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • MRC Global Inc (MRC)-石油・ガス分野:企業M&A・提携分析
    Summary MRC Global Inc (MRC) is a provider of pipe, valves and fittings. Its product portfolio include carbon steel pipe, carbon steel fittings and flanges, valve automation, stainless and alloy pipe, stainless and alloy fittings and flanges, industrial products, specialty products, oilfield product …
  • Avanza Bank Holding AB:企業の戦略・SWOT・財務分析
    Avanza Bank Holding AB - Strategy, SWOT and Corporate Finance Report Summary Avanza Bank Holding AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Ringier AG:企業の戦略的SWOT分析
    Ringier AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Osprey Medical Inc (OSP):企業の財務・戦略的SWOT分析
    Summary Osprey Medical Inc (Osprey Medical) is a medical device company that designs, develops, and manufacturers proprietary devices and monitoring systems. The company offers contrast removal system, which is designed to provide cardiologists with an advanced level of CIN protection in high risk p …
  • Nevro Corp (NVRO):医療機器:M&Aディール及び事業提携情報
    Summary Nevro Corp (Nevro) is a medical device company that offers products for the treatment of chronic pain. The company develops and commercializes senza spinal cord stimulation system (SCS), an evidence-based neuromodulation platform. Its solution for chronic pain also includes HF10 Therapy, whi …
  • Shinsei Bank Ltd:企業のM&A・事業提携・投資動向
    Shinsei Bank Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Shinsei Bank Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), dives …
  • Venoco, LLC-石油・ガス分野:企業M&A・提携分析
    Summary Venoco, LLC (Venoco), formerly known as Venoco, Inc., is an independent energy company. It carries out acquisition, exploration, exploitation and development of oil and natural gas properties. The company’s major onshore and offshore properties are located in Southern California. Venoco offs …
  • J.W. Ostendorf GmbH & Co KG:企業の戦略・SWOT・財務情報
    J.W. Ostendorf GmbH & Co KG - Strategy, SWOT and Corporate Finance Report Summary J.W. Ostendorf GmbH & Co KG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • BioView Ltd (BIOV):医療機器:M&Aディール及び事業提携情報
    Summary BioView Ltd (BioView) develops, manufactures and markets automated cell imaging and analysis solutions, which incorporate proprietary imaging, analysis and review technology. The technology provides automatic control of fully motorized fluorescent and bright-field microscopes fitted with hig …
  • Yantai Dongcheng Pharmaceutical Group Co Ltd (002675):製薬・医療:M&Aディール及び事業提携情報
    Summary Yantai Dongcheng Pharmaceutical Group Co Ltd (Yantai Dongcheng Pharma), formerly Yantai Dongcheng Biochemicals Co Ltd, is a developer, manufacturer, and marketer of biochemical API, chemical synthetic drugs, and Chinese medicines. The company offers its products under categories including he …
  • Shree Rama Newsprint Limited (RAMANEWS):企業の戦略的SWOT分析
    Shree Rama Newsprint Limited (RAMANEWS) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and m …
  • ONEOK Partners LP (OKS)-石油・ガス分野:企業M&A・提携分析
    Summary ONEOK Partners, L.P. (ONEOK Partners), a subsidiary of Oneok, Inc., is a midstream energy company. The company carries out gathering, processing, and storage and transportation of natural gas. It operates through master limited partnerships. ONEK Partners owns natural gas liquids (NGL) syste …
  • Rio Grande Electric Cooperative, Inc.:企業の戦略的SWOT分析
    Rio Grande Electric Cooperative, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and maj …
  • Alpine Immune Sciences Inc (NVLS):企業の財務・戦略的SWOT分析
    Summary Alpine Immune Sciences Inc (Alpine), formerly Nivalis Therapeutics Inc, is a pharmaceutical company that discovering and developing innovative, protein-based immunotherapies, immune synapse to treat cancer and autoimmune and inflammatory diseases. The has two products in the clinic for infla …
  • Karachaganak Petroleum Operating BV:企業の戦略的SWOT分析
    Karachaganak Petroleum Operating BV - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Savencia SA:企業の戦略・SWOT・財務情報
    Savencia SA - Strategy, SWOT and Corporate Finance Report Summary Savencia SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Navigator Holdings Ltd (NVGS):企業の財務・戦略的SWOT分析
    Summary Navigator Holdings Ltd (Navigator) operates as an oil and gas company that offers seaborne transportation of liquefied gases. The company transports ammonia, ethane, ethylene, ambient LPG, petrochemicals and LPG products. It provides fleet management, ship management, gas transportation and …
  • Neovasc Inc (NVC):企業の財務・戦略的SWOT分析
    Summary Neovasc Inc (Neovasc) is a medical device manufacturing company that manufactures, develops, and sells cardiovascular disease products. The company’s products include Neovasc reducer, Neovasc tiara, and Neovasc tissue products. Its Neovasc tiara is a novel transcatheter device that is design …
  • Gymboree Group, Inc.:企業の戦略的SWOT分析
    Gymboree Group, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆